1
|
Diaz-Barreiro A, Cereghetti G, Ortega Sánchez FG, Tonacini J, Talabot-Ayer D, Kieffer-Jaquinod S, Kissling VM, Huard A, Swale C, Knowles TPJ, Couté Y, Peter M, Francés-Monerris A, Palmer G. Oxidation-sensitive cysteines drive IL-38 amyloid formation. Cell Rep 2024; 43:114940. [PMID: 39488827 DOI: 10.1016/j.celrep.2024.114940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2023] [Revised: 07/16/2024] [Accepted: 10/17/2024] [Indexed: 11/05/2024] Open
Abstract
Interleukin (IL)-1 family cytokines are essential for host defense at epithelial barriers. The IL-1 family member IL-33 was recently linked to stress granules (SGs). Formation of SGs and other biomolecular condensates is promoted by proteins containing low-complexity regions (LCRs). Computational analysis predicts LCRs in six of the 11 IL-1 family members. Among these, IL-38 contains a long LCR including two amyloid cores. IL-38 localizes to intracellular granules in keratinocytes under oxidative stress (OS) and forms OS-induced amyloid aggregates in cells and in vitro. Interestingly, soluble and aggregated IL-38 are released from keratinocytes in an exosome-enriched extracellular vesicle fraction. Disulfide-bond mapping, in silico modeling, and mutational analysis suggest that oxidation-sensitive cysteines act as redox switches to alter IL-38 conformation and promote its aggregation. Finally, the presence of IL-38 granules in human epidermis facing environmental OS suggests that oxidation-induced amyloidogenesis, as an intrinsic property of IL-38, supports barrier function.
Collapse
Affiliation(s)
- Alejandro Diaz-Barreiro
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland.
| | - Gea Cereghetti
- Department of Chemistry, University of Cambridge, Cambridge, UK
| | - Francisco Gabriel Ortega Sánchez
- IBS Granada, Institute of Biomedical Research, Granada, Spain; Pulmonology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
| | - Jenna Tonacini
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland
| | - Dominique Talabot-Ayer
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland
| | | | - Vera Maria Kissling
- Particles-Biology Interactions Laboratory, Department of Materials Meet Life, Empa (Swiss Federal Laboratories for Materials Science and Technology), St. Gallen, Switzerland
| | - Arnaud Huard
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland
| | - Christopher Swale
- Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions and Immunity to Infection, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France
| | | | - Yohann Couté
- Université Grenoble Alpes, CEA, INSERM, UA13 BGE, CNRS, CEA, FR2048 Grenoble, France
| | - Matthias Peter
- Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland
| | | | - Gaby Palmer
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland
| |
Collapse
|
2
|
Conway SJ. Special Issue "2020 Feature Papers by JDB' Editorial Board Members". J Dev Biol 2021; 9:jdb9020021. [PMID: 34199485 PMCID: PMC8293115 DOI: 10.3390/jdb9020021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2021] [Accepted: 05/26/2021] [Indexed: 11/16/2022] Open
Affiliation(s)
- Simon J Conway
- HB Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 West Walnut Street, Room R4 W402E, Indianapolis, IN 46033, USA
| |
Collapse
|